NCT05810597View on ClinicalTrials.gov

A Research Study Looking at Similarity Between Tirzepatide Versions for Different Injection Devices

PHASE1CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

April 3, 2023

Primary Completion Date

July 17, 2023

Study Completion Date

July 17, 2023

Conditions
Healthy
Interventions
DRUG

Tirzepatide

Administered SC

DEVICE

Single Dose Pen

Used to administer tirzepatide SC

DEVICE

Multi-use Prefilled Pen

Used to administer tirzepatide SC

Trial Locations (3)

33143

Qps-Mra, Llc, South Miami

78209

ICON Early Phase Services, San Antonio

84124

ICON, Salt Lake City

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT05810597 - A Research Study Looking at Similarity Between Tirzepatide Versions for Different Injection Devices | Biotech Hunter | Biotech Hunter